COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 473: Articles 4721-4730  | Next

Syndromic surveillance as a predictive tool for health-related school absences in COVID-19 Sentinel Schools in Catalonia, Spain.
Ganem, F., Alonso, L., Colom-Cadena, A., Bordas, A., Folch, C., Soriano-Arandes, A., Casabona, J., COVID-19 Sentinel School Network Study Group of Catalonia
10.1101/2023.03.24.23287681 — Posted: 2023-03-24
Morbidity and mortality burden of COVID-19 in rural Madagascar: results from a longitudinal cohort and nested seroprevalence study
Garchitorena, A., Rasoloharimanana, L. T., Rakotonanahary, R. J., Evans, M. V., Miller, A. C., Finnegan, K. E., Cordier, L. F., Cowley, G., Razafinjato, B., Randriamanambintsoa, M., Andrianambinina, S., Popper, S., Hotahiene, R., Bonds, M. H., Schoenhals, M.
10.1101/2023.03.24.23287674 — Posted: 2023-03-24
Analysis of the risk and pre-emptive control of viral outbreaks accounting for within-host dynamics: SARS-CoV-2 antigen testing as a case study
Hart, W. S., Park, H., Jeong, Y. D., Kim, K. S., Yoshimura, R., Thompson, R. N., Iwami, S.
10.1101/2023.03.23.23287633 — Posted: 2023-03-24
SARS-CoV-2 convalescence and hybrid immunity elicits mucosal immune responses
Puhach, O., Bellon, M., Adea, K., Bekliz, M., Hosszu-Fellous, K., Sattonnet, P., Coudurier-Boeuf, S., Arm-Vernez, I., Kaiser, L., Eckerle, I., Meyer, B.
10.1101/2023.03.24.23287677 — Posted: 2023-03-24
Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial
Shapiro, A. E., Sarkis, E., Acloque, J., Free, A., Gonazalez-Rojas, Y., Hussain, R., Juarez, E., Moya, J., Parikh, N., Inman, D., Cebrik, D., Nader, A., Noormohamed, N., Wang, Q., Skingsley, A., Austin, D., Peppercorn, A., Agostini, M. L., Parra, S., Chow, S., Mogalian, E., Pang, P. S., Hong, D. K., Sager, J. E., Yeh, W. W., Alexander, E. L., Gaffney, L. A., Kohli, A.
10.1101/2023.03.21.23287410 — Posted: 2023-03-24
Adverse outcomes in SARS-CoV-2 infected pregnant mice are gestational age-dependent and resolve with antiviral treatment
Creisher, P. S., Perry, J. L., Zhong, W., Lei, J., Mulka, K. R., Ryan, H., Zhou, R., Akin, E. H., Liu, A., Mitzner, W., Burd, I., Pekosz, A., Klein, S. L.
10.1101/2023.03.23.533961 — Posted: 2023-03-23
Estimating the Impact of Pre-Exposure Prophylaxis (PrEP) on Mortality in COVID-19 Patients: A Causal Inference Approach
Subramanian, A., Huang, Y., Pinto, M. D., Downs, C. A., Rahmani, A.
10.1101/2023.03.16.23287365 — Posted: 2023-03-23
BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
Perera, D. J., Domenech, P., Babuadze, G. G., Naghibosadat, M., Alvarez, F., Koger-Pease, C., Labrie, L., Stuible, M., Durocher, Y., Piccirillo, C. A., Lametti, A., Fiset, P. O., Elahi, S. M., Kobinger, G. P., Gilbert, R., Olivier, M., Kozak, R., Reed, M. B., Ndao, M.
10.1101/2023.03.21.533720 — Posted: 2023-03-22
Evolving antibody evasion and receptor affinity of the Omicron BA.2.75 sublineage of SARS-CoV-2
Wang, Q., Li, Z., Guo, Y., Mellis, I. A., Iketani, S., Liu, M., Yu, J., Valdez, R., Lauring, A. S., Sheng, Z., Gordon, A., Liu, L., Ho, D. D.
10.1101/2023.03.22.533805 — Posted: 2023-03-22
COVID-19 Genome Surveillance: A Geographical Landscape and Mutational Mapping of SARS-CoV-2 Variants in Central India over Two Years
Khairnar, K., Tomar, S. S.
10.1101/2023.03.22.23287566 — Posted: 2023-03-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).